PainReform (NASDAQ:PRFX) Trading 11.9% Higher – Here’s What Happened

PainReform Ltd. (NASDAQ:PRFX)’s share price was up 11.9% on Friday . The company traded as high as $6.65 and last traded at $3.57. Approximately 18,456,644 shares traded hands during mid-day trading, an increase of 1,260% from the average daily volume of 1,356,704 shares. The stock had previously closed at $3.19.

Analyst Ratings Changes

Separately, Maxim Group reissued a “hold” rating on shares of PainReform in a research report on Thursday, October 24th.

PainReform Stock Performance

The firm has a market capitalization of $499,800.00, a P/E ratio of -0.02 and a beta of 0.64. The stock’s 50 day simple moving average is $3.46 and its 200 day simple moving average is $2.58.

About PainReform

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations.